25 XP   0   0   10

Medigus Ltd ADR
Buy, Hold or Sell?

Let's analyse Medigus together

PenkeI guess you are interested in Medigus Ltd ADR. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Medigus Ltd ADR. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about Medigus Ltd ADR

I send you an email if I find something interesting about Medigus Ltd ADR.

Quick analysis of Medigus (30 sec.)










What can you expect buying and holding a share of Medigus? (30 sec.)

How much money do you get?

How much money do you get?
$3.58
When do you have the money?
1 year
How often do you get paid?
13.2%

What is your share worth?

Current worth
$23.46
Expected worth in 1 year
$45.26
How sure are you?
34.2%

+ What do you gain per year?

Total Gains per Share
$25.38
Return On Investment
1,519.8%

For what price can you sell your share?

Current Price per Share
$1.67
Expected price per share
$0 - $3.08
How sure are you?
50%

1. Valuation of Medigus (5 min.)




Live pricePrice per Share (EOD)

$1.67

Intrinsic Value Per Share

$-120.88 - $-144.41

Total Value Per Share

$-97.42 - $-120.95

2. Growth of Medigus (5 min.)




Is Medigus growing?

Current yearPrevious yearGrowGrow %
How rich?$44.4m$52.4m-$736.2k-1.4%

How much money is Medigus making?

Current yearPrevious yearGrowGrow %
Making money-$5.2m-$179k-$5m-96.6%
Net Profit Margin-9.3%-399.9%--

How much money comes from the company's main activities?

3. Financial Health of Medigus (5 min.)




4. Comparing to competitors in the Medical Devices industry (5 min.)




  Industry Rankings (Medical Devices)  


Richest
#165 / 332

Most Revenue
#80 / 332

Most Profit
#255 / 332

Most Efficient
#156 / 332

What can you expect buying and holding a share of Medigus? (5 min.)

Welcome investor! Medigus's management wants to use your money to grow the business. In return you get a share of Medigus.

What can you expect buying and holding a share of Medigus?

First you should know what it really means to hold a share of Medigus. And how you can make/lose money.

Speculation

The Price per Share of Medigus is $1.67. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Medigus.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Medigus, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is $23.46. Based on the TTM, the Book Value Change Per Share is $5.45 per quarter. Based on the YOY, the Book Value Change Per Share is $0.39 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is $0.89 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Medigus.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 $% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share
Usd Eps-2.16-129.6%-1.66-99.7%-0.25-15.1%-0.61-36.3%-0.97-58.2%
Usd Book Value Change Per Share-5.41-323.7%5.45326.4%0.3923.1%1.0864.9%0.6237.0%
Usd Dividend Per Share0.1911.5%0.8953.5%0.000.0%0.1810.9%0.105.7%
Usd Total Gains Per Share-5.21-312.2%6.35379.9%0.3923.1%1.2775.8%0.7142.7%
Usd Price Per Share4.80-3.56-1.08-2.18-1.75-
Price to Earnings Ratio-0.55--2.03--52.13--22.46--11.15-
Price-to-Total Gains Ratio-0.92--0.23--60.35--16.25--9.59-
Price to Book Ratio0.20-0.62-5.91-5.86-3.30-
Price-to-Total Gains Ratio-0.92--0.23--60.35--16.25--9.59-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share1.67
Number of shares598
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.890.18
Usd Book Value Change Per Share5.451.08
Usd Total Gains Per Share6.351.27
Gains per Quarter (598 shares)3,794.37757.23
Gains per Year (598 shares)15,177.483,028.94
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
12139130391516743525943019
24278260773034487151876048
364163911645521130677819077
48555521556069817411037412106
510694651937587521771296815135
612833782329105226121556218164
7149729127110622930471815521193
81711010431012140634832074924222
91924911734813658339182334227251
102138813038715176043532593630280

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share0.04.00.00.0%2.010.00.016.7%2.018.00.010.0%4.034.00.010.5%4.034.00.010.5%
Book Value Change Per Share2.02.00.050.0%4.06.02.033.3%7.010.03.035.0%13.020.05.034.2%13.020.05.034.2%
Dividend per Share4.00.00.0100.0%5.00.07.041.7%5.00.015.025.0%5.00.033.013.2%5.00.033.013.2%
Total Gains per Share2.02.00.050.0%4.06.02.033.3%7.010.03.035.0%13.020.05.034.2%13.020.05.034.2%

Fundamentals of Medigus

About Medigus Ltd ADR

Medigus Ltd., a technology-based company, provides medical-related devices and products in the United States, Europe, Asia, Israel, and internationally. The company operates through Corporate, E-commerce, Online Advertising & Internet Traffic Routing, Online Event Management, and Others segments. It offers Medigus Ultrasonic Surgical Endostapler, an endoscopy system, which is used for the treatment of gastroesophageal reflux disease. The company also develops biological gels to protect patients against biological threats and reduce the intrusion of allergens and viruses through the upper airways and eye cavities. In addition, it provides digital advertising platform; and operates online stores for the sale of various consumer products on the Amazon online marketplace, as well as an online event management and ticketing platform. Further, the company develops, produces, and markets miniaturized imaging equipment, and visualization solutions; electric vehicles; and wireless vehicle battery charging technologies. Medigus Ltd. was incorporated in 1999 and is headquartered in Tel Aviv-Yafo, Israel.

Fundamental data was last updated by Penke on 2024-04-11 14:20:03.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a loss.
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating very inefficient.
The company is less efficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is just able to pay all its short-term debts.
The company is just able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is able to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is cheap.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.

1.1. Profitability of Medigus Ltd ADR.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Medigus earns for each $1 of revenue.

  • Above 10% is considered healthy but always compare Medigus to the Medical Devices industry mean.
  • A Net Profit Margin of -15.4% means that $-0.15 for each $1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Medigus Ltd ADR:

  • The MRQ is -15.4%. The company is making a huge loss. -2
  • The TTM is -9.3%. The company is making a loss. -1
Trends
Current periodCompared to+/- 
MRQ-15.4%TTM-9.3%-6.0%
TTM-9.3%YOY-399.9%+390.6%
TTM-9.3%5Y-779.1%+769.8%
5Y-779.1%10Y-1,099.8%+320.7%
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ-15.4%-11.2%-4.2%
TTM-9.3%-20.4%+11.1%
YOY-399.9%-13.3%-386.6%
5Y-779.1%-20.4%-758.7%
10Y-1,099.8%-24.9%-1,074.9%
1.1.2. Return on Assets

Shows how efficient Medigus is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Medigus to the Medical Devices industry mean.
  • -9.6% Return on Assets means that Medigus generated $-0.10 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Medigus Ltd ADR:

  • The MRQ is -9.6%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -5.6%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-9.6%TTM-5.6%-3.9%
TTM-5.6%YOY0.3%-5.9%
TTM-5.6%5Y-14.7%+9.1%
5Y-14.7%10Y-16.7%+1.9%
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ-9.6%-4.0%-5.6%
TTM-5.6%-4.6%-1.0%
YOY0.3%-4.2%+4.5%
5Y-14.7%-3.8%-10.9%
10Y-16.7%-4.8%-11.9%
1.1.3. Return on Equity

Shows how efficient Medigus is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Medigus to the Medical Devices industry mean.
  • -25.8% Return on Equity means Medigus generated $-0.26 for each $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Medigus Ltd ADR:

  • The MRQ is -25.8%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is -14.2%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-25.8%TTM-14.2%-11.6%
TTM-14.2%YOY-0.5%-13.8%
TTM-14.2%5Y-27.4%+13.2%
5Y-27.4%10Y-27.1%-0.4%
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ-25.8%-4.1%-21.7%
TTM-14.2%-5.6%-8.6%
YOY-0.5%-5.3%+4.8%
5Y-27.4%-6.1%-21.3%
10Y-27.1%-6.7%-20.4%

1.2. Operating Efficiency of Medigus Ltd ADR.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Medigus is operating .

  • Measures how much profit Medigus makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Medigus to the Medical Devices industry mean.
  • An Operating Margin of -8.6% means the company generated $-0.09  for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Medigus Ltd ADR:

  • The MRQ is -8.6%. The company is operating very inefficient. -2
  • The TTM is -6.5%. The company is operating very inefficient. -2
Trends
Current periodCompared to+/- 
MRQ-8.6%TTM-6.5%-2.1%
TTM-6.5%YOY-718.0%+711.4%
TTM-6.5%5Y-281.8%+275.3%
5Y-281.8%10Y-978.7%+696.9%
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ-8.6%-24.1%+15.5%
TTM-6.5%-16.4%+9.9%
YOY-718.0%-13.4%-704.6%
5Y-281.8%-19.9%-261.9%
10Y-978.7%-25.0%-953.7%
1.2.2. Operating Ratio

Measures how efficient Medigus is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Medical Devices industry mean).
  • An Operation Ratio of 1.09 means that the operating costs are $1.09 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of Medigus Ltd ADR:

  • The MRQ is 1.086. The company is inefficient in keeping operating costs low. -1
  • The TTM is 0.810. The company is less efficient in keeping operating costs low.
Trends
Current periodCompared to+/- 
MRQ1.086TTM0.810+0.276
TTM0.810YOY-5.620+6.430
TTM0.8105Y1.317-0.506
5Y1.31710Y9.323-8.007
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ1.0861.428-0.342
TTM0.8101.424-0.614
YOY-5.6201.396-7.016
5Y1.3171.416-0.099
10Y9.3231.375+7.948

1.3. Liquidity of Medigus Ltd ADR.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Medigus is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Medical Devices industry mean).
  • A Current Ratio of 1.30 means the company has $1.30 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of Medigus Ltd ADR:

  • The MRQ is 1.297. The company is just able to pay all its short-term debts.
  • The TTM is 1.019. The company is just able to pay all its short-term debts.
Trends
Current periodCompared to+/- 
MRQ1.297TTM1.019+0.279
TTM1.019YOY3.922-2.903
TTM1.0195Y4.396-3.377
5Y4.39610Y5.394-0.999
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ1.2972.685-1.388
TTM1.0192.697-1.678
YOY3.9223.466+0.456
5Y4.3963.629+0.767
10Y5.3943.507+1.887
1.3.2. Quick Ratio

Measures if Medigus is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Medigus to the Medical Devices industry mean.
  • A Quick Ratio of 1.28 means the company can pay off $1.28 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Medigus Ltd ADR:

  • The MRQ is 1.284. The company is able to pay all its short-term debts with the most liquid assets. +1
  • The TTM is 1.003. The company is just able to pay all its short-term debts with the most liquid assets.
Trends
Current periodCompared to+/- 
MRQ1.284TTM1.003+0.281
TTM1.003YOY2.830-1.827
TTM1.0035Y3.239-2.236
5Y3.23910Y5.214-1.975
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ1.2841.521-0.237
TTM1.0031.666-0.663
YOY2.8302.142+0.688
5Y3.2392.316+0.923
10Y5.2142.416+2.798

1.4. Solvency of Medigus Ltd ADR.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Medigus assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Medigus to Medical Devices industry mean.
  • A Debt to Asset Ratio of 0.48 means that Medigus assets are financed with 48.1% credit (debt) and the remaining percentage (100% - 48.1%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Medigus Ltd ADR:

  • The MRQ is 0.481. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.449. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.481TTM0.449+0.032
TTM0.449YOY0.217+0.233
TTM0.4495Y0.302+0.147
5Y0.30210Y0.275+0.027
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ0.4810.402+0.079
TTM0.4490.390+0.059
YOY0.2170.343-0.126
5Y0.3020.442-0.140
10Y0.2750.460-0.185
1.4.2. Debt to Equity Ratio

Measures if Medigus is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Medigus to the Medical Devices industry mean.
  • A Debt to Equity ratio of 129.8% means that company has $1.30 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Medigus Ltd ADR:

  • The MRQ is 1.298. The company is able to pay all its debts with equity. +1
  • The TTM is 1.101. The company is able to pay all its debts with equity. +1
Trends
Current periodCompared to+/- 
MRQ1.298TTM1.101+0.197
TTM1.101YOY0.359+0.742
TTM1.1015Y0.564+0.537
5Y0.56410Y0.478+0.086
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ1.2980.589+0.709
TTM1.1010.573+0.528
YOY0.3590.492-0.133
5Y0.5640.624-0.060
10Y0.4780.700-0.222

2. Market Valuation of Medigus Ltd ADR

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every $1 in earnings Medigus generates.

  • Above 15 is considered overpriced but always compare Medigus to the Medical Devices industry mean.
  • A PE ratio of -0.55 means the investor is paying $-0.55 for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Medigus Ltd ADR:

  • The EOD is -0.193. Based on the earnings, the company is expensive. -2
  • The MRQ is -0.555. Based on the earnings, the company is expensive. -2
  • The TTM is -2.027. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-0.193MRQ-0.555+0.362
MRQ-0.555TTM-2.027+1.473
TTM-2.027YOY-52.131+50.104
TTM-2.0275Y-22.459+20.432
5Y-22.45910Y-11.145-11.314
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
EOD-0.193-0.984+0.791
MRQ-0.555-1.709+1.154
TTM-2.027-2.190+0.163
YOY-52.131-2.629-49.502
5Y-22.459-2.300-20.159
10Y-11.145-1.789-9.356
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Medigus Ltd ADR:

  • The EOD is -0.194. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -0.557. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -6.276. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-0.194MRQ-0.557+0.363
MRQ-0.557TTM-6.276+5.719
TTM-6.276YOY-51.267+44.991
TTM-6.2765Y-33.174+26.898
5Y-33.17410Y-17.647-15.527
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
EOD-0.194-0.986+0.792
MRQ-0.557-1.578+1.021
TTM-6.276-2.973-3.303
YOY-51.267-6.238-45.029
5Y-33.174-4.850-28.324
10Y-17.647-5.292-12.355
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Medigus is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Medical Devices industry mean).
  • A PB ratio of 0.20 means the investor is paying $0.20 for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of Medigus Ltd ADR:

  • The EOD is 0.071. Based on the equity, the company is cheap. +2
  • The MRQ is 0.205. Based on the equity, the company is cheap. +2
  • The TTM is 0.618. Based on the equity, the company is cheap. +2
Trends
Current periodCompared to+/- 
EOD0.071MRQ0.205-0.133
MRQ0.205TTM0.618-0.413
TTM0.618YOY5.911-5.293
TTM0.6185Y5.863-5.246
5Y5.86310Y3.296+2.567
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
EOD0.0711.954-1.883
MRQ0.2052.376-2.171
TTM0.6182.468-1.850
YOY5.9113.169+2.742
5Y5.8633.906+1.957
10Y3.2964.273-0.977
2. Total Gains per Share

3. Holders & Insider Transactions

Let's take a look at which institutions, funds and insiders are holding shares of Medigus Ltd ADR.

3.1. Institutions holding Medigus Ltd ADR

Institutions are holding 0.286% of the shares of Medigus Ltd ADR.

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2023-12-31Rhumbline Advisers0.07620144300
2023-12-31UBS Group AG0.07610144153759.4027
2023-12-31Morgan Stanley - Brokerage Accounts0.05901118922470.4082
2023-12-31Advisor Group Holdings, Inc.0.0167031600
2023-12-31JPMorgan Chase & Co0.0014027270
2023-12-31Tower Research Capital LLC000-246-100
Total 0.229404345+1240+28.5%

3.2. Funds holding Medigus Ltd ADR

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2024-02-29Fidelity Nasdaq Composite Index0.0269051000
Total 0.0269051000.0%

4. Summary

4.1. Key Performance Indicators

The key performance indicators of Medigus Ltd ADR compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share---5.4065.451-199%0.385-1503%1.084-599%0.617-976%
Book Value Per Share--23.45820.655+14%7.255+223%7.385+218%5.699+312%
Current Ratio--1.2971.019+27%3.922-67%4.396-70%5.394-76%
Debt To Asset Ratio--0.4810.449+7%0.217+122%0.302+59%0.275+75%
Debt To Equity Ratio--1.2981.101+18%0.359+261%0.564+130%0.478+171%
Dividend Per Share--0.1920.894-79%-+100%0.182+6%0.096+101%
Eps---2.164-1.665-23%-0.252-88%-0.606-72%-0.973-55%
Free Cash Flow Per Share---2.154-1.344-38%-0.325-85%-0.518-76%-0.702-67%
Free Cash Flow To Equity Per Share---2.898-0.574-80%1.068-371%0.652-544%0.509-669%
Gross Profit Margin--1.1141.142-2%1.040+7%1.069+4%0.773+44%
Intrinsic Value_10Y_max---144.413--------
Intrinsic Value_10Y_min---120.879--------
Intrinsic Value_1Y_max---4.504--------
Intrinsic Value_1Y_min---4.418--------
Intrinsic Value_3Y_max---21.128--------
Intrinsic Value_3Y_min---20.017--------
Intrinsic Value_5Y_max---46.911--------
Intrinsic Value_5Y_min---42.888--------
Market Cap3164165.700-187%9094608.00033243634.900-73%312796859.526-97%171454719.184-95%91393353.859-90%
Net Profit Margin---0.154-0.093-39%-3.999+2504%-7.791+4972%-10.998+7060%
Operating Margin---0.086-0.065-24%-7.180+8280%-2.818+3189%-9.787+11323%
Operating Ratio--1.0860.810+34%-5.620+618%1.317-18%9.323-88%
Pb Ratio0.071-187%0.2050.618-67%5.911-97%5.863-97%3.296-94%
Pe Ratio-0.193+65%-0.555-2.027+266%-52.131+9301%-22.459+3950%-11.145+1910%
Price Per Share1.670-187%4.8003.560+35%1.079+345%2.176+121%1.754+174%
Price To Free Cash Flow Ratio-0.194+65%-0.557-6.276+1027%-51.267+9102%-33.174+5854%-17.647+3068%
Price To Total Gains Ratio-0.320+65%-0.921-0.234-75%-60.350+6455%-16.251+1665%-9.595+942%
Quick Ratio--1.2841.003+28%2.830-55%3.239-60%5.214-75%
Return On Assets---0.096-0.056-41%0.003-3407%-0.147+54%-0.167+74%
Return On Equity---0.258-0.142-45%-0.005-98%-0.274+6%-0.271+5%
Total Gains Per Share---5.2136.345-182%0.385-1453%1.266-512%0.713-831%
Usd Book Value--44447000.00051753500.000-14%52489750.000-15%30132700.000+48%19293053.755+130%
Usd Book Value Change Per Share---5.4065.451-199%0.385-1503%1.084-599%0.617-976%
Usd Book Value Per Share--23.45820.655+14%7.255+223%7.385+218%5.699+312%
Usd Dividend Per Share--0.1920.894-79%-+100%0.182+6%0.096+101%
Usd Eps---2.164-1.665-23%-0.252-88%-0.606-72%-0.973-55%
Usd Free Cash Flow---4081000.000-2823360.250-31%-1788000.000-56%-1616247.050-60%-1663931.230-59%
Usd Free Cash Flow Per Share---2.154-1.344-38%-0.325-85%-0.518-76%-0.702-67%
Usd Free Cash Flow To Equity Per Share---2.898-0.574-80%1.068-371%0.652-544%0.509-669%
Usd Market Cap3164165.700-187%9094608.00033243634.900-73%312796859.526-97%171454719.184-95%91393353.859-90%
Usd Price Per Share1.670-187%4.8003.560+35%1.079+345%2.176+121%1.754+174%
Usd Profit---8199999.000-5201729.500-37%-179000.000-98%-2383045.900-71%-2027591.042-75%
Usd Revenue--53385000.00035041952.000+52%8647500.000+517%8733990.400+511%4661819.211+1045%
Usd Total Gains Per Share---5.2136.345-182%0.385-1453%1.266-512%0.713-831%
 EOD+3 -5MRQTTM+7 -29YOY+11 -255Y+15 -2110Y+15 -21

4.2. Fundamental Score

Let's check the fundamental score of Medigus Ltd ADR based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-0.193
Price to Book Ratio (EOD)Between0-10.071
Net Profit Margin (MRQ)Greater than0-0.154
Operating Margin (MRQ)Greater than0-0.086
Quick Ratio (MRQ)Greater than11.284
Current Ratio (MRQ)Greater than11.297
Debt to Asset Ratio (MRQ)Less than10.481
Debt to Equity Ratio (MRQ)Less than11.298
Return on Equity (MRQ)Greater than0.15-0.258
Return on Assets (MRQ)Greater than0.05-0.096
Total4/10 (40.0%)

4.3. Technical Score

Let's check the technical score of Medigus Ltd ADR based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5028.457
Ma 20Greater thanMa 502.429
Ma 50Greater thanMa 1002.646
Ma 100Greater thanMa 2002.965
OpenGreater thanClose1.740
Total1/5 (20.0%)



Latest Balance Sheet

Balance Sheet of 2023-06-30. Currency in USD. All numbers in thousands.

Summary
Total Assets85,667
Total Liabilities41,220
Total Stockholder Equity31,763
 As reported
Total Liabilities 41,220
Total Stockholder Equity+ 31,763
Total Assets = 85,667

Assets

Total Assets85,667
Total Current Assets46,544
Long-term Assets39,123
Total Current Assets
Cash And Cash Equivalents 12,359
Short-term Investments 2,254
Net Receivables 29,206
Inventory 2,543
Other Current Assets 182
Total Current Assets  (as reported)46,544
Total Current Assets  (calculated)46,544
+/-0
Long-term Assets
Property Plant Equipment 982
Goodwill 9,047
Long Term Investments 6,647
Intangible Assets 21,989
Other Assets 458
Long-term Assets  (as reported)39,123
Long-term Assets  (calculated)39,123
+/-0

Liabilities & Shareholders' Equity

Total Current Liabilities35,879
Long-term Liabilities5,341
Total Stockholder Equity31,763
Total Current Liabilities
Short-term Debt 8,017
Short Long Term Debt 7,852
Accounts payable 18,587
Other Current Liabilities 4,826
Total Current Liabilities  (as reported)35,879
Total Current Liabilities  (calculated)39,282
+/- 3,403
Long-term Liabilities
Long term Debt 3,128
Capital Lease Obligations 612
Other Liabilities 1,766
Long-term Liabilities  (as reported)5,341
Long-term Liabilities  (calculated)5,506
+/- 165
Total Stockholder Equity
Retained Earnings -93,786
Accumulated Other Comprehensive Income 13,763
Other Stockholders Equity 111,786
Total Stockholder Equity (as reported)31,763
Total Stockholder Equity (calculated)31,763
+/-0
Other
Cash and Short Term Investments 14,613
Common Stock Shares Outstanding 1,633
Current Deferred Revenue4,449
Liabilities and Stockholders Equity 85,667
Net Debt -767
Net Invested Capital 42,743
Net Tangible Assets 727
Net Working Capital 10,665
Property Plant and Equipment Gross 982
Short Long Term Debt Total 11,592



Balance Sheet

Currency in USD. All numbers in thousands.

 Trend2023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-31
> Total Assets 
11,224
0
0
14,273
12,308
10,204
14,818
12,136
9,708
6,845
6,040
4,724
9,791
8,236
6,829
7,210
5,865
4,801
12,434
11,239
9,664
9,664
0
13,334
13,334
17,898
0
32,335
32,335
63,604
0
59,730
59,730
94,314
0
97,651
97,651
85,667
85,66797,65197,651094,31459,73059,730063,60432,33532,335017,89813,33413,33409,6649,66411,23912,4344,8015,8657,2106,8298,2369,7914,7246,0406,8459,70812,13614,81810,20412,30814,2730011,224
   > Total Current Assets 
10,618
0
0
13,844
11,947
9,924
14,542
11,871
9,438
5,912
4,993
3,586
9,057
7,541
6,359
6,814
5,530
4,563
12,324
11,134
9,569
9,569
8,279
8,279
8,279
12,053
24,045
24,045
24,045
33,441
31,654
31,654
31,654
45,958
0
52,258
52,258
46,544
46,54452,25852,258045,95831,65431,65431,65433,44124,04524,04524,04512,0538,2798,2798,2799,5699,56911,13412,3244,5635,5306,8146,3597,5419,0573,5864,9935,9129,43811,87114,5429,92411,94713,8440010,618
       Cash And Cash Equivalents 
6,203
0
0
10,803
11,010
8,705
13,089
10,308
7,499
4,488
3,868
3,001
8,420
2,444
1,245
2,828
1,520
4,032
11,925
10,625
8,787
8,787
0
7,036
7,036
10,172
0
22,363
22,363
29,642
0
24,025
24,025
22,141
0
20,065
20,065
12,359
12,35920,06520,065022,14124,02524,025029,64222,36322,363010,1727,0367,03608,7878,78710,62511,9254,0321,5202,8281,2452,4448,4203,0013,8684,4887,49910,30813,0898,70511,01010,803006,203
       Short-term Investments 
2,273
0
0
2,103
0
0
0
0
0
0
0
0
0
4,543
4,538
3,498
3,498
0
0
0
0
0
0
0
0
0
0
0
0
46
0
3,315
3,315
2,614
0
4,985
859
2,254
2,2548594,98502,6143,3153,3150460000000000003,4983,4984,5384,5430000000002,103002,273
       Net Receivables 
819
0
0
218
607
874
1,104
354
1,604
1,174
888
93
436
349
380
83
22
41
19
96
28
28
131
73
73
26
272
255
255
52
1,673
1,691
1,691
16,562
0
25,232
21,449
29,206
29,20621,44925,232016,5621,6911,6911,6735225525527226737313128289619412283380349436938881,1741,6043541,10487460721800819
       Inventory 
285
0
0
360
330
346
349
304
335
250
237
198
201
205
196
180
138
132
72
81
389
389
900
900
900
1,239
243
243
243
1,087
1,227
1,227
1,227
1,831
0
1,791
1,791
2,543
2,5431,7911,79101,8311,2271,2271,2271,0872432432431,239900900900389389817213213818019620520119823725033530434934633036000285
       Other Current Assets 
1,037
0
0
360
0
0
0
906
0
0
0
294
368
4,543
4,538
3,498
352
358
308
247
365
365
136
194
194
616
911
381
381
1,338
415
271
271
1,863
0
185
8,094
182
1828,09418501,8632712714151,3383813819116161941941363653652473083583523,4984,5384,543368294000906000360001,037
   > Long-term Assets 
606
0
0
429
360
280
276
264
270
933
1,047
1,138
734
695
470
396
335
238
110
105
0
95
0
5,055
5,055
5,845
0
8,290
8,290
30,163
0
28,076
28,076
48,356
0
45,393
44,996
39,123
39,12344,99645,393048,35628,07628,076030,1638,2908,29005,8455,0555,05509501051102383353964706957341,1381,04793327026427628036042900606
       Property Plant Equipment 
346
0
0
243
235
232
233
225
235
217
194
178
163
147
132
120
110
102
93
90
83
83
271
290
290
467
449
449
449
75
77
77
77
1,074
0
999
857
982
98285799901,074777777754494494494672902902718383909310211012013214716317819421723522523323223524300346
       Goodwill 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
812
0
926
926
7,083
0
9,068
9,068
9,047
9,0479,0689,06807,083926926081200000000000000000000000000000
       Long Term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
4,765
0
5,378
0
6,193
0
21,623
0
18,842
0
16,338
0
13,135
0
6,647
6,647013,135016,338018,842021,62306,19305,37804,76500000000000000000000000
       Intangible Assets 
33
0
0
48
51
48
43
39
35
30
27
26
21
17
14
16
16
16
17
15
12
12
0
0
0
0
0
0
0
7,515
0
7,395
7,395
22,293
0
21,794
21,936
21,989
21,98921,93621,794022,2937,3957,39507,5150000000121215171616161417212627303539434851480033
       Long-term Assets Other 
227
0
0
139
75
0
0
0
0
686
826
934
550
531
324
260
209
120
0
0
0
95
0
5,055
0
0
0
1,153
1,153
138
0
836
836
1,449
0
0
-44,996
0
0-44,996001,44983683601381,1531,1530005,05509500012020926032453155093482668600007513900227
> Total Liabilities 
1,691
0
0
1,239
1,342
1,554
1,899
1,959
2,203
2,098
1,971
1,797
6,133
2,702
2,472
1,699
1,396
1,442
3,583
3,160
3,223
3,223
0
5,203
5,203
4,461
0
6,141
6,141
9,700
0
8,297
8,297
41,125
0
42,962
42,962
41,220
41,22042,96242,962041,1258,2978,29709,7006,1416,14104,4615,2035,20303,2233,2233,1603,5831,4421,3961,6992,4722,7026,1331,7971,9712,0982,2031,9591,8991,5541,3421,239001,691
   > Total Current Liabilities 
965
0
0
1,031
998
1,137
1,704
1,852
2,101
1,997
1,838
1,334
1,174
991
825
957
717
728
984
1,362
1,624
1,624
3,365
3,365
3,365
4,403
3,514
3,514
3,514
6,666
6,639
6,639
6,639
33,177
0
37,627
37,627
35,879
35,87937,62737,627033,1776,6396,6396,6396,6663,5143,5143,5144,4033,3653,3653,3651,6241,6241,3629847287179578259911,1741,3341,8381,9972,1011,8521,7041,1379981,03100965
       Short-term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
610
0
0
0
858
0
0
0
119
119
85
0
60
60
138
0
927
927
9,462
0
6,742
6,742
8,017
8,0176,7426,74209,46292792701386060085119119000858000610000000000000000
       Short Long Term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
138
0
927
0
9,304
0
6,611
0
7,852
7,85206,61109,3040927013800000000000000000000000000000
       Accounts payable 
242
0
0
203
222
275
260
357
256
266
311
367
164
991
825
190
82
66
198
190
147
147
75
75
75
311
140
140
140
145
702
702
702
10,450
0
20,421
20,421
18,587
18,58720,42120,421010,450702702702145140140140311757575147147190198668219082599116436731126625635726027522220300242
       Other Current Liabilities 
723
0
0
757
776
862
1,444
1,102
1,845
1,731
1,527
774
1,010
874
718
96
635
662
786
83
1,477
663
2,042
2,669
2,669
1,535
1,999
3,245
3,245
6,275
3,478
4,902
4,902
13,157
0
10,415
17,206
4,826
4,82617,20610,415013,1574,9024,9023,4786,2753,2453,2451,9991,5352,6692,6692,0426631,47783786662635967188741,0107741,5271,7311,8451,1021,44486277675700723
   > Long-term Liabilities 
726
0
0
208
344
417
195
106
102
101
133
463
4,959
1,711
1,647
742
679
714
2,599
1,798
0
1,599
0
1,838
1,838
58
0
2,627
2,627
3,034
0
1,658
1,658
7,948
0
5,335
2,881
5,341
5,3412,8815,33507,9481,6581,65803,0342,6272,6270581,8381,83801,59901,7982,5997146797421,6471,7114,95946313310110210619541734420800726
       Long term Debt Total 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
33
0
0
0
0
0
0
0
0
0
0
0
0
0
0
000000000000003300000000000000000000000
       Other Liabilities 
0
0
0
208
0
0
0
106
102
101
133
463
4,959
1,711
1,647
742
679
714
2,599
1,798
1,599
1,599
1,805
1,805
5
5
2,580
2,580
2,301
2,301
969
969
2,850
2,850
0
0
1,766
1,766
1,7661,766002,8502,8509699692,3012,3012,5802,580551,8051,8051,5991,5991,7982,5997146797421,6471,7114,959463133101102106000208000
       Deferred Long Term Liability 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
836
836
863
863
0
0
0
0
0000863863836836000000000000000000000000000000
> Total Stockholder Equity
9,533
0
0
13,035
10,965
8,650
12,919
10,177
7,505
4,747
4,069
2,927
3,658
5,534
4,357
5,511
4,469
3,359
8,851
8,079
6,441
6,441
0
6,707
6,707
10,246
0
22,961
22,961
51,668
0
49,190
49,190
45,142
0
39,141
39,141
31,763
31,76339,14139,141045,14249,19049,190051,66822,96122,961010,2466,7076,70706,4416,4418,0798,8513,3594,4695,5114,3575,5343,6582,9274,0694,7477,50510,17712,9198,65010,96513,035009,533
   Common Stock
470
0
0
642
632
661
815
821
870
870
1,040
1,189
2,711
3,990
4,135
5,292
5,292
5,292
20,924
20,924
20,924
20,924
22,802
22,802
22,802
36,014
93,021
93,021
93,021
0
0
0
0
0
0
0
0
0
00000000093,02193,02193,02136,01422,80222,80222,80220,92420,92420,92420,9245,2925,2925,2924,1353,9902,7111,1891,04087087082181566163264200470
   Retained Earnings -93,786-85,586-85,5860-77,778-74,188-74,188-74,188-71,910-80,982-80,982-80,982-79,210-76,657-76,657-76,657-64,283-64,283-62,479-61,640-58,110-56,961-55,881-55,903-54,561-55,349-53,336-51,758-49,859-47,076-42,733-39,632-39,197-34,713-33,33700-32,144
   Capital Surplus 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
55,040
55,040
55,145
48,942
48,942
0
49,121
0
47,873
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0000000000000047,873049,121048,94248,94255,14555,04055,040000000000000000
   Treasury Stock00000000000000000000000000000000000000
   Other Stockholders Equity 
41,207
0
0
44,574
43,932
46,003
50,571
50,901
53,612
53,612
54,640
54,874
55,883
55,735
55,777
61,392
55,770
55,875
48,942
70,558
679
49,121
12,689
2,388
2,388
40,012
10,922
2,994
197
110,597
12,816
110,759
110,759
111,519
0
111,519
124,727
111,786
111,786124,727111,5190111,519110,759110,75912,816110,5971972,99410,92240,0122,3882,38812,68949,12167970,55848,94255,87555,77061,39255,77755,73555,88354,87454,64053,61253,61250,90150,57146,00343,93244,5740041,207



Balance Sheet

Currency in USD. All numbers in thousands.




Cash Flow

Currency in USD. All numbers in thousands.




Income Statement

Currency in USD. All numbers in thousands.


Latest Income Statement (annual, 2022-12-31)

Gross Profit (+$)
totalRevenue91,858
Cost of Revenue-77,406
Gross Profit14,45214,452
 
Operating Income (+$)
Gross Profit14,452
Operating Expense-23,033
Operating Income-13,784-8,581
 
Operating Expense (+$)
Research Development4,853
Selling General Administrative14,174
Selling And Marketing Expenses4,006
Operating Expense23,03323,033
 
Net Interest Income (+$)
Interest Income0
Interest Expense-4,080
Other Finance Cost-1,771
Net Interest Income-2,309
 
Pretax Income (+$)
Operating Income-13,784
Net Interest Income-2,309
Other Non-Operating Income Expenses0
Income Before Tax (EBT)-10,097-17,471
EBIT - interestExpense = -17,864
-10,097
-6,128
Interest Expense4,080
Earnings Before Interest and Taxes (EBIT)-13,784-6,017
Earnings Before Interest and Taxes (EBITDA)-11,988
 
After tax Income (+$)
Income Before Tax-10,097
Tax Provision-111
Net Income From Continuing Ops-10,208-10,208
Net Income-10,208
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses100,439
Total Other Income/Expenses Net3,6872,309
 

Technical Analysis of Medigus
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Medigus. The general trend of Medigus is BEARISH with 100.0% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Medigus's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (-100.0%) Bearish trend (100.0%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Medigus Ltd ADR.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is 0/(-1 +1).

  • Between support/resistance: The price is trading between support and resistance lines.

The bullish price targets are: 2.11 < 2.9999 < 3.08.

The bearish price targets are: .

Tweet this
Medigus Ltd ADR Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Medigus Ltd ADR. The current mas is .

The long score for the Moving Averages is 0/14.
The longshort score for the Moving Averages is -14/(-14 +14).

  • MA 20 trending down: The MA 20 is trending down. -1
  • Close < MA 20: The price is below the MA 20. -1
  • MA 20 < MA 50: The MA 20 is lower than the MA 50. -1
  • MA 20 < MA 100: The MA 20 is lower than the MA 100. -1
  • MA 20 < MA 200: The MA 20 is lower than the MA 200. -1
  • MA 50 trending down: The MA 50 is trending down. -1
  • Close < MA 50: The price is below the MA 50. -1
  • MA 50 < MA 100: The MA 50 is lower than the MA 100. -1
  • MA 50 < MA 200: The MA 50 is lower than the MA 200. -1
  • MA 100 trending down: The MA 100 is trending down. -1
  • Close < MA 100: The price is below the MA 100. -1
  • MA 100 < MA 200: The MA 100 is lower than the MA 200. -1
  • MA 200 trending down: The MA 200 is trending down. -1
  • Close < MA 200: The price is below the MA 200. -1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Medigus Ltd ADR Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Medigus Ltd ADR. The current macd is -0.20998942.

The long score for the Moving Average Convergence/Divergence (MACD) is 0/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is -4/(-4 +4).

  • MACD line < signal line: The MACD line is below the signal line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Medigus price going down in the near term. -2
  • MACD < 0: The MACD is below the zero line (centerline), it indicates a bearish signal for Medigus. This means that the short-term moving average is lower than the long-term moving average, signaling negative momentum and suggesting a higher likelihood of the Medigus price continuing to fall in the near future. It indicates that sellers are gaining control, and there is negativism in the market, leading to potential price decreases. -1
  • Trending down: The MACD line is trending down. This indicates that the short-term moving average is falling faster than the long-term moving average, suggesting negative momentum in the market. This signals that sellers are becoming more active and insecure, leading to potential price decreases as traders anticipate further losses and are willing to sell at lower prices. -1
Medigus Ltd ADR Daily Moving Average Convergence/Divergence (MACD) ChartMedigus Ltd ADR Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Medigus Ltd ADR. The current adx is 17.12.

The long score for the Directional Movement Index (DMI) is 0/7.
The longshort score for the Directional Movement Index (DMI) is -1/(-7 +7).

  • PLUS_ID < MINUS_DI: The +DI line is below the -DI line. This indicates a bearish signal in the market, as the negative directional movement is currently stronger than the positive directional movement, showing that sellers have the upper hand. Market psychology suggests that traders are pessimistic, expecting further price decreases, and are more willing to sell Medigus shares, leading to potential downward momentum in its price. -1
  • PLUS_ID < MINUS_DI && ADX < 25 && ADX trending down: The ADX is below 25 and indicates a weak or no trend. Also, the ADX is declining so there is no trend indication.
Medigus Ltd ADR Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Medigus Ltd ADR. The current sar is 2.87732736.

The long score for the Parabolic SAR is 0/1.
The longshort score for the Parabolic SAR is -1/(-1 +1).

  • Close < SAR: The price is below the SAR. It's generally considered a bearish signal. -1
Medigus Ltd ADR Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Medigus Ltd ADR. The current rsi is 28.46. The current phase is Oversold in bear market.

The long score for the Relative Strength Index (RSI) is 2/13.
The longshort score for the Relative Strength Index (RSI) is 2/(-13 +13).

  • Oversold in bear market: Short-term excessive selling, potential for relief rally. Be cautious, consider taking short-term long positions. +1
  • Trending up: The RSI is trending up. +1
Medigus Ltd ADR Daily Relative Strength Index (RSI) ChartMedigus Ltd ADR Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Medigus Ltd ADR. The current phase is Oversold in bear market.

The long score for the Stochastic Oscillator is 3/6.
The longshort score for the Stochastic Oscillator is 0/(-6 +6).

  • STOCH < 50: The STOCH %K is below 50. There are more sellers than buyers. -1
  • STOCH < 20: The STOCH %K is below 20 and oversold. -2
  • STOCH %K line > STOCH %D line: The STOCH %K line is above the STOCH %D line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Medigus price going up in the near term. +2
  • Trending up: The STOCH %K is trending up. +1
Medigus Ltd ADR Daily Stochastic Oscillator ChartMedigus Ltd ADR Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Medigus Ltd ADR. The current cci is -213.42062903.

The long score for the Commodity Channel Index (CCI) is 0/1.
The longshort score for the Commodity Channel Index (CCI) is -1/(-1 +1).

  • CCI < -100: The CCI is below -100, it indicates that the price is significantly below its average, suggesting a potential oversold condition. -1
Medigus Ltd ADR Daily Commodity Channel Index (CCI) ChartMedigus Ltd ADR Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Medigus Ltd ADR. The current cmo is -48.87847926.

The long score for the Chande Momentum Oscillator (CMO) is 0/1.
The longshort score for the Chande Momentum Oscillator (CMO) is -1/(-1 +1).

  • CMO < 0: The CMO is below 0, the momentum of the price is negative, indicating a potential downtrend in the price. -1
Medigus Ltd ADR Daily Chande Momentum Oscillator (CMO) ChartMedigus Ltd ADR Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Medigus Ltd ADR. The current willr is -90.76552652.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is -1/(-1 +1).

  • WILLR < -80: The Williams %R is below -80. This indicates that the price is in oversold territory, suggesting a potential price correction or trend reversal to the upside. -1
Medigus Ltd ADR Daily Williams %R ChartMedigus Ltd ADR Daily Williams %R Chart

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Medigus Ltd ADR.

Medigus Ltd ADR Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Medigus Ltd ADR. The current atr is 0.2372269.

Medigus Ltd ADR Daily Average True Range (ATR) ChartMedigus Ltd ADR Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Medigus Ltd ADR. The current obv is 4,235,674.

Medigus Ltd ADR Daily On-Balance Volume (OBV) ChartMedigus Ltd ADR Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Medigus Ltd ADR. The current mfi is 30.49.

The long score for the Money Flow Index (MFI) is 0/2.
The longshort score for the Money Flow Index (MFI) is -1/(-2 +2).

  • MFI < 50: -1
Medigus Ltd ADR Daily Money Flow Index (MFI) ChartMedigus Ltd ADR Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Medigus Ltd ADR.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2023-12-05STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-06STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-08CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2023-12-12WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2023-12-14MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2023-12-15STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-18MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2023-12-19MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2023-12-21STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2023-12-22WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2023-12-26STOCH LONG EXITThe %K line crosses below the %D line.
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2023-12-28SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-12-29MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-04STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-05STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-01-08STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-01-09STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-01-11CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-16STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-01-17STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-19STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-01-22STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-23CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-01-26STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-29CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-01-31STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-02-02STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-05DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-02-06STOCH LONG EXITThe %K line crosses below the %D line.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-02-07WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-02-08MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-02-09STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-12SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-02-13STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-20MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-02-22SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-02-23WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-02-26BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-02-27STOCH SHORT EXITThe %K line crosses above the %D line.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-02-28STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-29STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-01MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-03-05STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-03-06MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-03-07CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-03-08SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-03-11STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-03-12WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-03-13STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-14SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-03-15STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-18STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-19DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2024-03-20DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2024-03-22STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-25DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2024-03-26CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-03-27DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-03-28STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-04-01STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-02DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2024-04-03STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-04MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-04-05MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-04-09MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-04-10MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-04-11CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-04-12STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-15WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-04-16STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-17DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-19SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-04-22MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-04-24MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-04-25DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-04-29STOCH SHORT EXITThe %K line crosses above the %D line.

6.3. Candlestick Patterns

Medigus Ltd ADR Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Medigus Ltd ADR based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5028.457
Ma 20Greater thanMa 502.429
Ma 50Greater thanMa 1002.646
Ma 100Greater thanMa 2002.965
OpenGreater thanClose1.740
Total1/5 (20.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of Medigus with someone you think should read this too:
  • Are you bullish or bearish on Medigus? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Medigus? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Medigus Ltd ADR

I send you an email if I find something interesting about Medigus Ltd ADR.


Comments

How you think about this?

Leave a comment

Stay informed about Medigus Ltd ADR.

Receive notifications about Medigus Ltd ADR in your mailbox!